Renal (kidney) disease is growing in prevalence, often developing as a complication of diabetes. Abbott renal testing assays enable laboratories to use high-quality biomarkers for diagnosis and management of patients with acute kidney injury and chronic kidney disease.
For in vitro diagnostic use.
Our assays have been developed to assist in disease detection and therapeutic intervention. Cystatin C can be used to estimate the glomerular filtration rate (eGFR), a standard marker for chronic renal disease diagnosis and monitoring, while NGAL allows diagnosis of acute kidney damage.
| Renal |
| Beta2 Microglobulin |
| Creatinine |
| Creatinine (Enzymatic) |
| Cystatin C* |
| Microalbumin (Urine) |
| NGAL |
| Protein (Urine/CSF) |
| Urea Nitrogen |
| Uric Acid |
*In development. Not commercially available.
Login or register for a new account on the Lab Central customer portal. Here you can view assay specific package inserts for intended use, important safety information and manage your personalized lab metrics.
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
Our extensive assay menu helps physicians make timely, informed decisions throughout the continuum of care.
Learn how Abbott has helped physicians evaluate suspected mild traumatic brain injury (mTBI).
Discover how Alinity uses powerful technology to help redefine and improve operational productivity and confidence in your laboratory.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
